CRBP · Corbus Pharmaceuticals Holdings, Inc.
$10.09
+0.01 (+0.10%)
At close · Aug 14
Market Cap
$195.15M
Shares
19.34M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2020-08-06 | 2023-05-31 | $150,000,000 | $69,100,000 as of 2026-03-31 | — | 10-Q , filed 2026-05-12 |
Key facts
CIK
1595097
CUSIP
21833P301
13F (30d)
102 filings
100 filers
Visit website
Investor relations